PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2032 participants.
Also called NCT01314313
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,032 participants
- Sponsor
- Registry
-
NCT01314313
-
- Other papers using this trial's data
- 10-Year Randomized Outcomes of Transcatheter or Surgical Aortic Valve Replacement in Intermediate-Risk Aortic Stenosis
- Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk
- Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement
- Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial
- Incidence and Clinical Significance of Worsening Tricuspid Regurgitation Following Surgical or Transcatheter Aortic Valve Replacement: Analysis From the PARTNER IIA Trial
- One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis
- Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT01314313. Randomized; no masking; primary purpose treatment. Start 2011-03 (actual); primary completion 2016-01 (actual). Results posted on 2018-08-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk
- Acronym
- PII A
- Condition
- Symptomatic Severe Aortic Stenosis
- Intervention (Device)
- TAVR Implantation with SAPIEN XT
- Intervention (Device)
- SAVR Implantation
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct01314313- Content hash
1e06a932c513ded99110dce3e4bb958de306656774cb95eb30173bdaae9f28ed